Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gastro-enteropancreatic neuroendocrine tumor × Fluorodeoxyglucose F18 × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 15 Stomach Neoplasms 5 Carcinoma, Transitional Cell 5 Uterine Cervical Neoplasms 4 Sarcoma 4 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Multiple Myeloma 4 Lung Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Hepatocellular 4 Urinary Bladder Neoplasms 3 Thyroid Neoplasms 3 Neuroendocrine Tumors 3 Neoplasms 3 Cholangiocarcinoma 3 Anus Neoplasms 3 Testicular Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumor 2 Pheochromocytoma 2 Paraganglioma 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Mouth Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell, Marginal Zone 2 Hodgkin Disease 2 Carcinoma, Renal Cell 2

Interventions

lutetium Lu 177 dotatate 5 pasireotide 2 amino-acid, glucose, and electrolyte solution 2 Octreotide 2 Everolimus 2 177Lu-octreotide, DOTA(0)-Tyr(3)- 2 zimberelimab 1 lanreotide 1 irinotecan sucrosofate 1 gallium Ga 68 dotatate 1 copper dotatate CU-64 1 abemaciclib 1 Temozolomide 1 Sunitinib 1 Receptor-Like Protein Tyrosine Phosphatases, Class 2 1 PM 01183 1 Oxaliplatin 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Lutetium-177 1 Lutetium 1 Leucovorin 1 Irinotecan 1 Ipilimumab 1 Ga(III)-DOTATOC 1 Folfox protocol 1 Fluorouracil 1 E-7386 1 Disulfides 1 Cryotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡